Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
9.20
+0.38 (4.37%)
At close: Jun 27, 2025, 4:00 PM
8.86
-0.34 (-3.64%)
After-hours: Jun 27, 2025, 4:00 PM EDT
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$139,254
Profits / Employee
$4,904,159
Market Cap
7.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ADXN News
- 3 days ago - Addex Shareholders Approve All Resolutions at Annual General Meeting - GlobeNewsWire
- 9 days ago - Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 days ago - Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewsWire
- 22 days ago - Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models - GlobeNewsWire
- 25 days ago - Addex Convenes Annual General Meeting 2025 - GlobeNewsWire
- 6 weeks ago - Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - GlobeNewsWire
- 2 months ago - Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery - GlobeNewsWire
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript - Seeking Alpha